These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 15114537)

  • 1. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI)
    Am J Kidney Dis; 2004 May; 43(5 Suppl 1):S1-290. PubMed ID: 15114537
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing hypertensive kidney disease: the critical role of combination therapy.
    Bakris GL
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):93S-94S. PubMed ID: 15837550
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypertension during the course of kidney diseases].
    Wiecek A
    Przegl Lek; 1997; 54(11):773-6. PubMed ID: 9501687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis].
    Goicoechea MA
    Nefrologia; 2004; 24 Suppl(6):161-71, 187-235. PubMed ID: 15696905
    [No Abstract]   [Full Text] [Related]  

  • 6. Which antihypertensive agents in chronic kidney disease?
    Levey AS; Uhlig K
    Ann Intern Med; 2006 Feb; 144(3):213-5. PubMed ID: 16461967
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.
    Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2010 Sep; 56(3):423-6. PubMed ID: 20728787
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy for hypertension associated with kidney disease].
    Suzuki H
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731
    [No Abstract]   [Full Text] [Related]  

  • 9. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changing the natural history of essential arterial hypertension by antihypertensive treatment].
    Suárez C; Ruilope LM
    Med Clin (Barc); 1994 Apr; 102(16):624-9. PubMed ID: 8208040
    [No Abstract]   [Full Text] [Related]  

  • 11. An editorial update: what level of blood pressure control in chronic kidney disease?
    Levey AS; Mulrow CD
    Ann Intern Med; 2005 Jul; 143(1):79-81. PubMed ID: 15998758
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric hypertension: a review for the primary care provider.
    Rowan S; Adrogue H; Mathur A; Kamat D
    Clin Pediatr (Phila); 2005 May; 44(4):289-96. PubMed ID: 15864360
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathologic basis and treatment considerations in chronic kidney disease-related hypertension.
    Sica D; Carl D
    Semin Nephrol; 2005 Jul; 25(4):246-51. PubMed ID: 16202697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension in the course of renal diseases].
    Gaciong Z
    Pol Arch Med Wewn; 1999; 102 Spec No():85-90. PubMed ID: 10916632
    [No Abstract]   [Full Text] [Related]  

  • 16. The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.
    Bakris GL; Ritz E;
    Clin Exp Nephrol; 2009 Feb; 13(1):96-9. PubMed ID: 19184272
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?].
    Schmieder RE
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556
    [No Abstract]   [Full Text] [Related]  

  • 18. Should reducing nocturnal blood pressure be a therapeutic target in CKD? The time is ripe for a clinical outcomes trial.
    Rahman M; Appel LJ
    Am J Kidney Dis; 2007 Dec; 50(6):901-3. PubMed ID: 18037089
    [No Abstract]   [Full Text] [Related]  

  • 19. Can calcium channel blockers preserve renal function better than diuretics during antihypertensive treatment?
    Fukuda M; Kimura G
    Arch Intern Med; 2005 Jun; 165(11):1312; author reply 1312-3. PubMed ID: 15956015
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hypertension in mild kidney insufficiency].
    Schrey A; Hartmann H; Jutzler GA; Grund R; Forst HT
    Ther Ggw; 1982 Aug; 121(8):465-75. PubMed ID: 6753222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.